Timing of Testosterone Level Measurement with Twice-Weekly Injections
For twice-weekly testosterone injections (e.g., 70 mg subcutaneously on Sunday and Wednesday), measure serum testosterone at the midpoint between injections—approximately 3-4 days after the most recent injection—to capture a representative steady-state level rather than a peak or trough.
Rationale for Midpoint Timing
When administering short-acting testosterone esters twice weekly, you create a more stable pharmacokinetic profile compared to traditional every-two-week dosing. However, timing of blood draw remains critical for accurate interpretation:
- Peak levels occur 2-5 days after injection with traditional intramuscular testosterone cypionate 1
- With twice-weekly dosing, the pharmacokinetic curve is compressed, but the principle remains: you want to avoid both the immediate post-injection peak and the pre-injection trough
- Measuring at midpoint (3-4 days post-injection) provides the most representative assessment of your patient's average testosterone exposure 2
Practical Implementation
For your specific Sunday/Wednesday schedule:
- Optimal timing: Draw blood on Tuesday or Wednesday morning (3-4 days after Sunday injection, before Wednesday injection)
- This captures a level that reflects neither peak nor trough, giving you the most clinically useful information for dose adjustment
Morning Draw Still Matters
Always obtain fasting morning samples (8-11 AM) even with twice-weekly dosing 1, 3. While exogenous testosterone blunts the circadian rhythm seen with endogenous production, morning draws remain the standard for several reasons:
- Consistency with diagnostic criteria and reference ranges
- Better comparison with baseline pre-treatment values
- Evidence shows significant differences in testosterone levels even in older men when drawn outside the 8-11 AM window (411.7 vs 368.3 ng/dL, p=0.0003) 3
Monitoring Schedule
Once you've established the appropriate timing for blood draws:
- First follow-up: 1-2 months after initiating therapy to assess efficacy and consider dose adjustment 1
- Subsequent monitoring: Every 3-6 months for the first year 1
- Long-term: Annually thereafter if stable 1
At each visit, measure:
- Serum testosterone level
- Hematocrit or hemoglobin
- PSA (with digital rectal exam)
- Assess symptom response and side effects 1
Common Pitfalls to Avoid
Do not draw levels immediately before the next injection (trough timing). While some clinicians use trough levels to ensure adequate coverage, with twice-weekly dosing this may underestimate your patient's average exposure and lead to unnecessary dose escalation 2.
Do not draw levels within 24-48 hours of injection (peak timing). This will overestimate average exposure and may falsely suggest supraphysiologic dosing, potentially leading to inappropriate dose reduction 2.
Document everything: Record the specific testosterone ester, dose, concentration, route, injection interval, timing of last injection, and timing of bloodwork. Without this context, testosterone results are nearly impossible to interpret correctly 2.
Target Levels
Aim for mid- to upper-normal range (450-600 ng/dL or approximately 15-21 nmol/L) 1, 4. However, if your patient reports adequate clinical response with levels in the low-normal range, dose adjustment is unnecessary 1. Conversely, suboptimal response with low-normal levels warrants dose increase.
The goal is physiologic replacement with stable symptoms and interpretable labs—not maximizing testosterone levels 2.